Cholesterol Drugs May Be Good Candidates For Managed Care Pull Throughs
Executive Summary
Cholesterol-lowering agents may be good candidates for managed care pull through programs following the recent change in National Cholesterol Education Program guidelines, participants at a recent workshop on pharmaceutical managed care marketing suggested.
You may also be interested in...
Cholesterol Therapy Guidelines Stress Need To Consider Cost, Treat To Goal
The National Cholesterol Education Program treatment guidelines encourage physicians to restrict drug therapy only to high risk patients - but expand the definition of high risk to include as many as 36 mil. people in the U.S.
Harvard Pilgrim Weighing Prilosec Promotion In Face Of Less Expensive PPIs
Harvard Pilgrim Health Care is weighing the benefits of promoting AstraZeneca's Prilosec (omeprazole) within the managed care organization's network in the face of near-term patent expiration and less costly proton pump inhibitors.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011